| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |